Sign inJoin waitlistJoin the waitlist

David Raleigh

Associate Program Director, Department of Radiation Oncology · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

Department of Radiation Oncology · University of California (San Francisco) School of Medicine
Present
NRG Brain Tumor Committee
2026–Present
UCSF Brain Tumor Center
Present

Radiation Oncology
University of California (San Francisco) School of Medicine
2013–2017
2015–2016
Preliminary Internal Medicine
Kaiser Permanente Medical Center
2012–2013
University of Chicago
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
2008–2012
University of California, Berkeley
2000–2004

Research

Tight junction pore and leak pathways: a dynamic duo
Review · Annual Review of Physiology · 2011 · 691 citations
Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo
The Journal of Cell Biology · 2010 · 397 citations
Glioblastoma remodelling of human neural circuits decreases survival
Nature · 2023 · 341 citations

Stephen Magill
58 papers · 24 as a resident
William Chen
55 papers · 29 as a resident
Michael McDermott
48 papers
Steve Braunstein
46 papers · 2 as a resident
Arie Perry
45 papers · 25 as a fellow
AC
Abrar Choudhury
41 papers · 15 as a resident
Harish Vasudevan
37 papers · 24 as a resident
Philip Theodosopoulos
36 papers
Kanish Mirchia
34 papers · 15 as a fellow
Calixto-Hope Lucas
33 papers · 30 as a resident
Javier Villanueva-Meyer
33 papers · 1 as a fellow
Joanna Phillips
26 papers

Grants

Overcoming Medulloblastoma Resistance to Treatment Using in vivo Perturb-Seq and Preclinical Therapeutics
National Cancer Institute · R01
Contact PI · $680.6K · University of California, San Francisco
2026–2031
Interplay of Tumor Genomic and Immune Characteristics and External Drivers of Health to Improve Cancer Health Outcomes
National Cancer Institute · U54
Project lead · $908.4K · University of California, San Francisco
2025–2030
Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management
National Cancer Institute · P01
Project lead · $1.4M · University of California, San Francisco
2007–2029
Validation, Translation, and Clinical Implementation of a Gene Expression Biomarker to Predict Meningioma Outcomes and Radiotherapy Responses
National Cancer Institute · UH3
Contact PI · $613.1K · University of California, San Francisco
2025–2028

Clinical trials

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
Principal investigator · Recruiting
University of California, San Francisco
2026–2032